Research progress of HIV-associated myelopathy

<p>The wide usage of highly active antiretroviral therapy (HAART) leads to reduction of the occurence rate of focal or diffuse neurological damage caused by human immunodeficiency virus (HIV) infection, which prominently improves the living quality of HIV-infected patients. Despite this pro...

Full description

Bibliographic Details
Main Authors: Kun HONG, Chang LIU, Zhao-hua MENG, Hua YIN, Jun-ying HE
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2016-08-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/1439
_version_ 1828842866421530624
author Kun HONG
Chang LIU
Zhao-hua MENG
Hua YIN
Jun-ying HE
author_facet Kun HONG
Chang LIU
Zhao-hua MENG
Hua YIN
Jun-ying HE
author_sort Kun HONG
collection DOAJ
description <p>The wide usage of highly active antiretroviral therapy (HAART) leads to reduction of the occurence rate of focal or diffuse neurological damage caused by human immunodeficiency virus (HIV) infection, which prominently improves the living quality of HIV-infected patients. Despite this progress, about 70% of HIV-infected patients develop neurological complications. Although neurological disease typically occurs in the advanced stage of the disease or after severe damage of immune functions, it may also occur during early stage of the infection. HIV-associated myelopathy is a common complication of immunodeficiency syndrome and its typical pathological appearence is vacuolar degeneration. In many patients the clinical manifestations of vacuolar myelopathy are in fact limited to non-specific sphincter or sexual dysfunction, and may remain completely asymptomatic. Even when motor and sensory symptoms become evident, the diagnosis is often complicated by a concomitant peripheral neuropathy. The purpose of this study is to summarize pathogenesis, clinical manifestations, pathological features, diagnosis and treatment of HIV-associated myelopathy.</p><p> </p><p><strong>DOI: </strong>10.3969/j.issn.1672-6731.2016.08.004</p>
first_indexed 2024-12-12T20:33:43Z
format Article
id doaj.art-2b6906df81fe4d90a3f5461cecbf07bb
institution Directory Open Access Journal
issn 1672-6731
language English
last_indexed 2024-12-12T20:33:43Z
publishDate 2016-08-01
publisher Tianjin Huanhu Hospital
record_format Article
series Chinese Journal of Contemporary Neurology and Neurosurgery
spelling doaj.art-2b6906df81fe4d90a3f5461cecbf07bb2022-12-22T00:12:57ZengTianjin Huanhu HospitalChinese Journal of Contemporary Neurology and Neurosurgery1672-67312016-08-011684814841417Research progress of HIV-associated myelopathyKun HONG0Chang LIU1Zhao-hua MENG2Hua YIN3Jun-ying HE4Department of Neurology, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, ChinaDepartment of Rehabilitation, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, ChinaDepartment of Emergency, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, ChinaDepartment of Neurology, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, ChinaDepartment of Neurology, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, China<p>The wide usage of highly active antiretroviral therapy (HAART) leads to reduction of the occurence rate of focal or diffuse neurological damage caused by human immunodeficiency virus (HIV) infection, which prominently improves the living quality of HIV-infected patients. Despite this progress, about 70% of HIV-infected patients develop neurological complications. Although neurological disease typically occurs in the advanced stage of the disease or after severe damage of immune functions, it may also occur during early stage of the infection. HIV-associated myelopathy is a common complication of immunodeficiency syndrome and its typical pathological appearence is vacuolar degeneration. In many patients the clinical manifestations of vacuolar myelopathy are in fact limited to non-specific sphincter or sexual dysfunction, and may remain completely asymptomatic. Even when motor and sensory symptoms become evident, the diagnosis is often complicated by a concomitant peripheral neuropathy. The purpose of this study is to summarize pathogenesis, clinical manifestations, pathological features, diagnosis and treatment of HIV-associated myelopathy.</p><p> </p><p><strong>DOI: </strong>10.3969/j.issn.1672-6731.2016.08.004</p>http://www.cjcnn.org/index.php/cjcnn/article/view/1439HIVSpinal cord diseasesReview
spellingShingle Kun HONG
Chang LIU
Zhao-hua MENG
Hua YIN
Jun-ying HE
Research progress of HIV-associated myelopathy
Chinese Journal of Contemporary Neurology and Neurosurgery
HIV
Spinal cord diseases
Review
title Research progress of HIV-associated myelopathy
title_full Research progress of HIV-associated myelopathy
title_fullStr Research progress of HIV-associated myelopathy
title_full_unstemmed Research progress of HIV-associated myelopathy
title_short Research progress of HIV-associated myelopathy
title_sort research progress of hiv associated myelopathy
topic HIV
Spinal cord diseases
Review
url http://www.cjcnn.org/index.php/cjcnn/article/view/1439
work_keys_str_mv AT kunhong researchprogressofhivassociatedmyelopathy
AT changliu researchprogressofhivassociatedmyelopathy
AT zhaohuameng researchprogressofhivassociatedmyelopathy
AT huayin researchprogressofhivassociatedmyelopathy
AT junyinghe researchprogressofhivassociatedmyelopathy